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ABSTRACT 
 
Aims: The objective of the present study was to prepare fractions of polyphenols based on their 
ability to stimulate release of interleukin-2 (IL-2) from a human T-cell line, Jurkat, in the presence or 
absence of phorbol myristic acetate (PMA), and to identify the candidate components responsible 
for this activity. 
Study Design: Rhizophora mangle L. [Rhizophoraceae] bark was collected in occident zone of 
CUBA, was boiled in distilled water and freezer dried for its fractionation. 
Methodology: The IL2-releasing the activity of different fractions were quantified using a BD 
Original Research Article 
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OptEIA Human IL-2 ELISA kit using Jurkat Cells and PMA during the test. The ESI–MS fingerprints 
of the extracts [ESI-MS/MS] were acquired by the negative ion mode using a Micromass-Waters Q-
TOF mass spectrometer. 
Results: Guided fractionations from Rhizophora mangle bark aqueous extracts in the evaluation of 
releasing activity of interleukin 2-stimulated and unstimulated with Jurkat T cells in the presence of 
PMA showed that the butanolic fraction had an interleukin 2 production of 250 pg mL-1 and an 
89.9% yield of procyanidins. Mass spectral studies of the butanolic fraction reflected the presence 
of compounds that varied between 1000-1333 m/z, indicating the presence of procyanidins up to a 
tetramer polymerization level linked to glycosides based on monomeric units [epicatechin / 
catechin]. An increase of IL-2, without prior stimulation with PMA, in the Jurkat T cell model, had 
not been previously reported for the phenolic compounds. 
Conclusion: The compounds characterized preliminarily confirmed the structural diversity of 
polyphenols present in Rhizophora mangle L plant and its capacity to stimulate release of IL 2.  
 
 
Keywords: Rhizophora mangle L; interleukin -2; procyanidins; Jurkat T cell. 
 
1 INTRODUCTION 
 
Historically, medicinal plants have provided a       
rich source of potentially active secondary 
metabolites which can be used not only as 
pharmaceuticals, but also as a starting point for 
the synthesis of analogous compounds. A 
continual effort is being made to clarify the 
chemical composition of phytochemicals and 
their relation to pharmacological activity [1]. As 
such, polyphenols have been extensively studied 
and their qualitatively or quantitatively content 
depends on the phenological conditions of the 
plant [2]. 
 
Rhizophora mangle L, or red mangrove, is a 
plant known in the Caribbean countries for use in 
traditional medicines. Preparations have been 
used for treating diverse pathologies such as 
diarrhea, fungal infections and healing of open 
surgical wounds, among others [3-6]. The 
chemical characterization of Rhizophora mangle 
bark aqueous extracts showed the major 
component (54.8%) to be polyphenolic 
compounds, with 80% polymeric and 20% 
hydrolyzable tannins respectively. Non-tannic 
components include carbohydrate (17.5%), 
saturated and unsaturated fatty acids (4.0%), 
phytosterols (0.028%), volatile or semi-volatile 
components (0. 02%) and essential oils [7]. 
 
It has been previously reported that Rhizophora 
mangle L bark aqueous extracts have a range of 
pharmacological properties, including antiseptic 
and antibacterial [8-11], accelerating the wound 
healing process [12-14], antioxidant [15,16], anti-
inflammatory [17], anti-ulcerogenic [18], and anti-
mutagenic [19].  
 
A study of aging leaves of R. mangle L showed 
that the major components were flavonoid 
glycosides and a complex mixture of condensed 
tannins based mainly on [+]-catechin and [−]-
epicatechin with A-type and B-type linkages [20]. 
Other research with R. mangle L leaves revealed 
that procyanidins with 2,3-cis stereochemistry 
and monoglycoside flavan-3-ols polymers with 
polymerization degree up to 12 are responsible 
for the free radical scavenging activity [21]. 
 
In recent years, the effect of polyphenols from 
natural sources on the immune system, either to 
stimulate or to inhibit the production of 
interleukins and IFN-γ during the inflammatory 
response has been reported [22-25]. 
 
The structural diversity and complex physico-
chemical properties of polyphenols in mangrove 
plants suggest a potential source of new 
bioactive compounds. Thus the objective of the 
work was to prepare fractions of polyphenols 
based on their ability to stimulate release of 
interleukin-2 (IL-2) from a human T-cell line, 
Jurkat, in the presence or absence of phorbol 
myristic acetate (PMA), and to identify the 
candidate components responsible for this 
activity. 
 
2. MATERIALS AND METHODS 
 
2.1 Collection of the Plant 
 
Rhizophora mangle L. [Rhizophoraceae] bark 
was collected during April 2010 in the town of 
Bahia Honda, Pinar del Rio province, Cuba. 
Specialists from the Herbarium of the National 
Botanical Garden confirmed its identity, and a 
sample with the code 65368 HAJB was 
deposited. 
 
2.2 Extraction and Fractionation 
 
a) Fresh bark was boiled in distilled water (1:7.5 
w/v) for 20 min. The plant extract was cleared by 
filtration and the supernatant (TE) was freeze-
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dried and preserved at 4-8°C in a nylon bag. 50 
mL of distilled water were added to the 
lyophilized product and stirred until completely 
dissolved. Polymerised phenolic compounds 
were precipitated with sodium chloride as 
described [26]. The precipitate was extracted 
with n-butanol using a Buchi B811 extraction 
system [upper heating 4, lower heating 16, 2:00 
hours]. The butanol extract [BF] was dried by 
rotary evaporation [55°C]. The supernatant 
obtained after precipitation with NaCl was 
extracted 3 times with ethyl acetate (1:2 v/v)            
The organic phase was concentrated to 
approximately 30 mL and then 100 mL of 
chloroform were added. It was left in the cold 
overnight and centrifuged. The precipitate 
obtained was called EAF. Both products were 
kept dry at 4°C until analysis. 
 
b) Butanol subfraction (BSF): a column [30.0 x 
1.0 cm id] was packed with 8.5 g of C18 (Fuji 
Silysia Chemical Ltd.; Chromatore ODS 100-200 
mesh) using methanol. BF was completely 
dissolved in 150 mL methanol. The sample was 
then added to the column. A mixture of water and 
acetonitrile (80:20, v/v) was passed through the 
column. Then, the first band was collected in 
three fractions as follows: the bottom 1, the 
middle 2 and the top 3. Another mixture of water 
and acetonitrile (60:40, v/v) was then passed 
through the column and a second band was 
collected in three fractions: the bottom 4, the 
middle 5 and the top 6. The flow rate was 0.5 mL 
min-1. The fractions collected were dried by 
rotary evaporation and kept at 2-4°C until 
analysis.   
 
c) BSF2 subfractions: BSF2 was dissolved in 
methanol (4 mg mL-1) and applied to a C18 
reverse-phase column (250 x 10.0 mm, 5µm; 
RESTEK Kromasil C18) using a liquid 
chromatograph (PerkinElmer Series 200 with 
variable UV detector at 280 nm). The mobile 
phase consisted of water (solvent A) and 
acetonitrile (solvent B) with the following 
gradients: 5% solvent B for 10 min., from 5% of B 
to 15% in 15 min., then to 100% of B in 5 min., 
and finally 100% of B until 35 min. of run time. 
The flow rate was 3 mL min-1. For the analysis of 
the chromatograms, the software Totalchrom 
version 6.3.1 was used. 
 
2.3 Electrospray Ionization-mass Spectro-
metry Fingerprinting 
 
ESI–MS fingerprints of the extracts (ESI-MS/MS) 
were acquired in the negative ion mode using a 
Micromass-Waters Q-TOF mass spectrometer 
(Manchester, UK). Capillary and cone voltages 
were set to -3500 V and -30 V, respectively, with 
a desolvation temperature of 150°C. For mass 
spectra (ESI-MS/MS) of selected mass 
compounds, collision energy was optimized for 
each component, varying from 15 to 50 V. The 
extracts were diluted in a solution containing 
100% chromatographic grade methanol (Sigma, 
St. Louis, MO, USA). The extracts were analyzed 
by direct insertion negative ion mode ESI-MS 
fingerprinting. To tune the LCQ for polyphenols, 
the voltages on the lenses were optimised in the 
Tune function of the MassLynx 4.0 SP4, SCN 
519 software in negative ion mode. 
 
2.4 Determination of Interleukin-2 (IL-2)  
 
Stimulation of IL-2 release was assayed using 
the Jurkat T cell line purchased from the 
European Collection of Authenticated Cell 
Cultures (Porton Down, Salisbury, UK). 
Concentrations of 10, 50 and 100 µg mL-1 
samples (TE, BF and EAF) obtained during 
fractionation were individually added into wells of 
a 96-well cell culture plate, and then 0.5 mL were 
added to 1x106 Jurkat cells mL-1, while BF 
subfractions were prepared at a final 
concentration of 100 µg mL-1. All the mixtures 
were incubated in a CO2 incubator (5 % CO2) for 
two hours at 37°C, after which phorbol-12-
myristate 13-acetate (PMA) (Sigma, St. Louis, 
MO, USA) was added at a final concentration of 
50 ng mL-1. Cells were incubated for a further 18 
hours in the CO2 incubator. Supernatants were 
removed and centrifuged for 5 min. at 800 rpm at 
4°C for the quantification of IL-2. Controls of the  
PMA (50 ng mL-1) and dimethyl sulfoxide (0.1 %) 
were processed in the same way. Mixtures with 
PMA and without PMA were denominated as 
stimulated and unstimulated cells respectively. 
 
Levels of endogenously produced IL-2 were 
quantified using a BD OptEIA Human IL-2 ELISA 
kit (BD Biosciences, San Diego, CA, USA). 
 
2.5 MTT Cytotoxicity Assay 
 
Jurkat T cells (106 cells mL-1) were mixed with TE 
fractions, BF, (300, 100, 50 µg mL-1) BSF2 and 
Epicatechin (EC) (100 µg mL-1) and incubated for 
2 hours in the CO2 incubator, then stimulated 
with PMA (50 ng mL-1) and incubated again             
for 18 hours. The  solution of (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT)) was added to each mixture, 
forming a purple colored product (formazan) 
  
 
 
Armas et al.; EJMP, 15(2): 1-10, 2016; Article no.EJMP.26743 
 
 
 
4 
 
insoluble in mitochondria living cells, and a 
solution solubilizing was added to solubilize the 
formed formazan. The absorbance was 
measured at 570 nm in a microplate reader. The 
percentage of living cells was calculated relative 
to DMSO control (0.1%) [27]. 
 
2.6 Statistical Analysis 
 
All results are expressed as the mean ± standard 
deviation of three experiments. The results of IL-
2 were compared for each fraction using the 
procedure and Kruskal-Wallis nonparametric 
ANOVA. 
 
3. RESULTS AND DISCUSSION 
 
Jurkat T-cells are widely used in the evaluation of 
IL-2 releasing the activity of extracts from natural 
products [28,29], where the stimulation of T cells 
by mitogenic lectin (PHA) and PMA activates a 
cascade of events enabling transcription and 
secretion of IL-2. This regulation process of IL-2 
at a transcriptional level is strongly involved in T 
cell proliferation and in the normal immune 
response [30]. 
 
The effect of the different fractions of an aqueous 
extract of Rhizophora mangle L bark in 
stimulating release of IL-2, with and without PMA 
co-stimulation, is shown in Fig. 1. TE and BF 
fractions had the highest response of stimulating 
IL-2 release, both in a concentration-dependent 
manner, in comparison with the control groups 
(cells and DMSO (0.1%)). In contrast, EAF 
fraction had no significant activity (Fig. 1). 
Cytotoxic effects were not observed for any of 
the extracts and controls tested [MTT assay, 
data are not shown], thus confirming that the 
effects are only due to the stimulation of IL-2 
production by the polyphenolic compounds.  
 
Data are the mean+SD of three separate 
experiments. For cells co-stimulated with PMA, 
significant differences between controls (cells or 
0.1% DMSO) and cells treated with fractions              
(TE, BF or EAF at 10, 50, or 100 µg mL-1) are 
marked by lower case letters, P=0.01. For cells 
not co-stimulated with PMA, significant 
differences between controls ([cells or 0.1% 
DMSO) and cells treated with R. Mangle extracts 
are marked by upper case letters, P=0.05. TE 
total extract; BF butanolic fraction; EAF ethyl 
acetate fraction. 
 
The aqueous extract of the Rhizophora mangle L 
bark contains a high percentage of polyphenolic 
structures (54.74%), of which polymeric 
compounds are a majority (80%) and correspond 
with the butanol fraction (BF), while in the ethyl 
acetate fraction (EAF), hydrolyzable tannins 
predominated [7]. The total extract fractionation 
with n-butanol gave a fraction with mass of 
860±77 mg (89±9.9%), while the yield from            
the ethyl acetate fraction was only 10%. In                
the last fraction, the flavan 3-ol compounds              
were predominant: catechin, epigallocatechin 
gallate, epigallocatechin, epicatechin and 
gallocatechingallate. Catechin and 
epigallocatechin gallate were used as markers in 
semisolid and liquid products formulated from the 
R. mangle L bark aqueous extracts [31,32].  
 
 
 
Fig. 1. Effects of TE, BF and EAF preparations from R. mangle on stimulation of secretion of 
IL-2 from Jurkat T cells 
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A study of IL2 release in the presence of 
polyphenols with leukemic T cells stimulated with 
PMA and PWA (CCRF-CEM) showed that 
kaempferol and quercetin increased release. 
However, tea extract from ‘Yabukita’ as well as 
‘Benifuki’ and catechins (EGCG, EGC, ECG and 
EC) did not increase IL-2 release [33], which is 
consistent with our findings in terms of ethyl 
acetate fraction. 
 
The results of previous studies confirm that 
tannin polymers are responsible for the 
stimulation of IL-2 release, however the total 
extract stimulates release of IL-2, similar to or 
bigger than that obtained by EA fraction, which 
indicates a synergistic effect. This agrees with 
the statements of other authors that the 
oligomers are primarily responsible for the 
activities attributed to condensed tannins 
(astringent effect and pharmacological activities). 
 
The fact that extracts from TE and BF (100 and 
50 µg mL-1) showed an increase of IL-2 in the 
test without PMA, co-stimulation was an 
important finding, since it had not been 
previously reported for polyphenolic compounds.  
 
A study of isolated procyanidin fractions 
(monomer through decamer) from cocoa [50 µg 
mL-1] reported that the transcription of IL-2 in 
resting PBMC was not stimulated; however, 
when induced with PHA, the pentamer, hexamer 
and heptamer fractions caused a 61–73% 
inhibition in IL-2 gene expression, depending on 
the polymerization degree [30]. 
 
Fig. 2 shows that the six BF subfractions could 
stimulate release of IL-2 from Jurkat cells in both 
the presence and absence of PMA. Subfraction 2 
(BSF 2 (80-20)) with a yield of 28.1±7.8% (Table 
1) induced production of IL-2 of 272 pg mL-1, and 
fractions 60:40 (1), 80:20 (2), 60:40 (2), 80:20 (1) 
and 60:40 (3) induced IL-2 in a range from 78.4 
to 150 pg/mL. 
 
Data are the mean+SD of three separate 
experiments. For cells co-stimulated with PMA, 
significant differences between controls (0.1% 
DMSO) and cells treated with BSF are marked 
by lower case letters, P=0.01. For cells not co-
stimulated with PMA significant differences 
between controls (0.1% DMSO) and cells treated 
with R. mangle butanol sub-fractions (BSF) are 
marked by upper case letters, P=0.05. 
 
Having identified BF subfraction 2 (BSF2) as the 
highest-releasing activity of IL-2, it was analyzed 
by electrospray mass spectroscopy (ESI MS) 
with varying collision energy (Fig. 3). The results 
indicate a maximum molecular weight ranging 
from 1000-1333 m/z which corresponds to a 
tetramer, indicating a fraction which is a mixture 
of oligomeric procyanidins [34,35]. Moreover, 
they show at least two series of compounds, with 
base cores of epicatechin or catechin glycosides 
present as monomers, dimers or trimers. 
 
Table 1. Results in percentages of BF 
subfraction fractionation by column 
chromatography [C18] and the BSF2 yield 
average 
 
H2O: 
CH3CN v/v 
% [10 
mg BF] 
Lots of 
BSF 
% vs BF 
1[80-20] 4.0 BSF2 
01/0907 
35.0 
2[80-20]-BSF2 23.0 BSF2 
02/0907 
17.0 
3[80-20] 14.0 BSF2 
03/1107 
25.0 
1[60-40] 3.0 BSF2 
04/1107 
29.0 
2[60-40] 9.0 BSF2 
05/1207 
36.0 
3[60-40] 1.0 BSF2 
06/1207 
18.0 
Total    54.0% BSF2 
01p/0907 
28.0 
BSF2 
02p/0907 
37.0 
Average 28.1±7.8 
 
The purification of the BSF2 fraction by 
preparative HPLC showed 12 peaks, from which 
one presented IL2 releasing activity with 62% 
yield. Table 2 shows a fractionation bioguide 
summary, obtained in the last process yielding 
11.5% of the fraction that showed activity and 
50% with respect to the previous stage. This was 
not achieved with the methodology used to 
define a single compound. The peak No 12 was 
the only one showing a releasing activity of IL 2, 
the latter was confirmed by spectral analysis to 
detect the presence of homologous series, and 
monomeric units were identified by analyzing 
MS-MS (Table 3).  
 
In a preliminary study, a spectral relation was 
observed between the ions 1045, 596 and 451 
m/z fractionation pattern with MS-MS ion 1045 
m/z and ions containing the afore mentioned. It 
can be inferred that in presence of cyanidin 
dimer, catechin joined glucoside and rhamnoside 
(MSMS 1045). The remaining fragment ions 
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showed a distinct splitting pattern with each 
other, which indicated the presence of other 
compounds that could be caused by the 
fragmentation of p-methoxybenzoic rhamnoside 
(MSMS 283.16) gallocatechin: catechin-
rhamnoside (MSMS 739.12) mono-, di and 
triglucoside cyanidin or mono and di quercetin 
glucoside (MSMS 883.86) 
 
  
 
Fig. 2. Effects of R. mangle butanolic subfractions [100 µg/mL] on stimulation of IL-2 secretion 
from Jurkat T cells 
 
 
 
Fig. 3. Mass spectrum of butanol extract fraction 2 (BSF2) performed at different collision 
energies 
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Table 2. Summary bioguide fractionation through IL-2 production in Jurkat T cells activated 
and not activated with PMA 
 
Stages of process mass [mg] Production IL2 Selected 
fraction  
 
Yield vs TE % 
With 
PMA 
pg mL-1 
Without 
PMA 
pg mL-1 
Total extract [TE] 1000 275 110   
Butanolic fraction [BF] 860 250 120 ***** 86.0 
Etyl Acetate fraction [EAC] 90 52 10   
Fractionation  of BF in C18 
column 
 
1[80-20] BSF1 34.6 100 10   
2[80-20] BSF2 197.8 265 75 ***** 23.0 
3[80-20] BSf3 120.4 105 35   
1[60-40] BSF4 25.8 150 40   
2[60-40] BSF5 77.4 105 20   
3[60-40] BSF6 0.86 75 10   
∑ BSF 456.86     
Fractionation  of BSF 2 in  
HPLC using C18 Column 
 
P3 3.96 20 2   
P7 19.8 21 2   
P7a 11.8 20 4   
P9 13.8 18    
P10 5.9 19 2   
P11 7.9 20    
P12 99 140 60 ***** 11.5 
∑ BSF 158.2     
 
Table 3. Negative ion ESI mass spectra of P12.MS2 of ions (m/z 1045, 596, 451, 883, 739, 283 y 
255) 
 
Peak 12 MS2 1045 MS2 596 MS2 451 MS2 883,86 MS2 739,12 MS2 283,16 MS2 255 
m/z m/z m/z m/z m/z m/z m/z m/z 
455.477 10,459.215 596.418 4,506.578 8,840.029 7,403.038 2,837.029 2,558.232 
9,157.360 9,361.237 4,507.601 3,427.341 7,323.185 7,381.439 2,832.974 2,251.379 
9,008.250 8,942.154 3,419.052 3,418.607 6,045.509 5,875.344 2,832.649 1,081.501 
8,838.597 5,967.592 3,409.084 3,408.551 5,685.187 5,864.957 1,042.434 971.062 
7,760.754 5,966.887 3,229.193 2,190.296 3,409.796 4,347.762 742.281 75.169 
7,740.764 4,508.624 1,771.032 1,770.839 2,890.504 3,389.013     
7,391.257 450.801     2,870.392 2,890.176     
7,381.308 3,410.329     1,771.415 1,771.160     
6,123.931 289             
5,964.533 2,870.963             
5,505.730 1,771.737             
4,866.067               
4,517.015               
4,506.783               
3,768.144               
3,409.084               
2,831.595               
2,551.764               
2,150.333               
1,911.006               
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A study by Kandill et al. [20], where they 
evaluated changes in the phenolic compounds 
present in the leaves of Rhizophora mangle L 
during development, they found that most of the 
flavonoid glycosides had a core of quercetin, 
while myricetin compounds appeared in lower 
concentrations, and kaenferol di-glycosides. 
Flavonoids were accompanied by a mixture of 
condensed tannins, where the core base was 
formed by catechin and epicatechin, and joined 
with type A and B linked glycosides. Another 
report on R. mangle L indicated that a complete 
characterization of compounds could not be 
reached because of a high polymerization giving 
products of molecular weights ranging from 
999.34～4751.54 m/z; however, there was only a 
glucoside molecule in  the monomer units 
[catechin / epicatechin] [21].  
 
Other reports in different species (Bruguiera 
gymnorrhiza [36]; Harcornia speciosa bark [37], 
Anisophyllea dichostyla bark [38]) describe the 
presence of procyanidins bonded glycosides 
units and their relation to the treatment of various 
diseases. It is noteworthy that procyanidins may 
inhibit or enhance the production of IL-2 and 
interferon gamma (IFN-gamma) [39,40], results 
that indicate that polyphenols play an important 
role in the biological regulation. 
 
All these reports confirm that there is a great 
diversity of polymeric tannins, which is given by 
structural variability of monomeric units, 
hydroxylation patterns in the A and B rings, 
different stereochemistry at the chiral centers of 
the carbons in position 2 and 3 as well as the 
distinct location of interflavonoides links [41]. 
However, these reports indicate that, in the 
structure of these compounds, there are 
underlying polymer units attached to glucose or 
ramnoside groups, something that matches the 
candidate structures being proposed in this 
paper. 
 
Finally the potential for modulation of immune 
responses by the butanolic fraction is suggested 
from a study that used a rat model of 
experimental colitis [42]. Treatment with the 
butanolic fraction of R mangle was able to 
protect against mucosal injury in the colon, 
providing further incentive to identify individual 
active components.  
 
4. CONCLUSIONS 
 
Rhizophora mangle L stimulate release of IL-2 
from Jurkat cells in both the presence and 
absence of PMA. 
The compounds that was characterized 
preliminarily, confirmed the structural diversity of 
polyphenols present in Rhizophora mangle L 
bark with high potential for modulation of immune 
responses. 
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